respiratory
COPD

Are blood eosinophils a biomarker of response to ICS?

Sponsored by Boehringer Ingelheim Pty Ltd

Research suggests that a minority of patients with COPD have elevated numbers of blood eosinophils that might predict a response to treatment with inhaled corticosteroids. We caught up with Peter Calverley, a Professor of Respiratory Medicine at the University of Liverpool and a senior investigator in the WISDOM study to get his view on on ...

Already a member?

Enter your email to keep reading.


OR